Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-06-06
2010-12-28
Low, Christopher (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S130100, C435S287200
Reexamination Certificate
active
07858323
ABSTRACT:
The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
REFERENCES:
patent: 6573361 (2003-06-01), Bunkers et al.
patent: 6610508 (2003-08-01), Hentze et al.
patent: 6686147 (2004-02-01), Scanlan et al.
patent: 6783961 (2004-08-01), Edwards et al.
patent: 6943241 (2005-09-01), Isogai et al.
patent: 7115416 (2006-10-01), Edwards et al.
patent: 7205117 (2007-04-01), Robinson et al.
patent: 7214498 (2007-05-01), Nelson
patent: 7368527 (2008-05-01), Rosen et al.
patent: 7402403 (2008-07-01), Robinson et al.
patent: 2003/0092009 (2003-05-01), Palm
patent: 2004/0044181 (2004-03-01), Tang et al.
patent: 2005/0032065 (2005-02-01), Afar et al.
patent: 2006/0014138 (2006-01-01), Chinnaiyan
patent: 2008/0153113 (2008-06-01), Robertson et al.
patent: 1074617 (2001-02-01), None
patent: 1270724 (2003-01-01), None
patent: WO0218424 (2002-03-01), None
patent: WO 03/010199 (2003-02-01), None
patent: WO 03/064593 (2003-08-01), None
CAS entry 142:2133341 (database entry 2005).
Wang et al (2005 New England Journal of Medicine 353:1224-1235).
Autoantibodies in Prostate Cancer (Letters to the Editor 2005 New England Journal of Medicine 353:2815-2817).
Hufton et al. “Serological antigen selection of phage displayed colorectal tumour cDNA libraries.” Biochemical Society Transactions. vol. 26, p. S5, entire document (1998).
Miller et al. “Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers.” Proteomics. vol. 3, pp. 56-63, p. 58 (2003).
Eisen et al. “Cluster analysis and display of genome-wide expression patterns.” Proceedings of the National Academy of Sciences USA. vol. 95, pp. 14863-14868 (1998).
Li et al. “Gene Assessment and Sample Classification for Gene Expression Data Using a Genetic Algorithm/k-nearest Neighbor Method.” Combinatorial Chemistry & High Throughput Screening. vol. 4, pp. 727-739 (2001).
Golub et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring.” Science. vol. 286, pp. 531-537(1999).
Crescenzi and Giuliani. “The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data.” FEBS Letters. vol. 507, pp. 114-118 (2001).
Denis and Green. “A novel, mitogen-activated nuclear kinase is related to aDrosophiladevelopmental regulator.” Genes & Development. vol. 10, pp. 261-271 (1996).
Denis et al. “RING3 Kinase Transactivates Promoters of Cell Cycle Regulatory Genes through E2F.” Cell Growth & Differentiation. vol. 11, pp. 471-424 (2000).
Kanno et al. “Selective Recognition of Acetylated Histones by Bromodomain Proteins Visualized in Living Cells.” Molecular Cell. vol. 13, pp. 33-43 (2004).
Gingras et al. “Regulation of translation initiation by FRAP/mTOR.” Genes & Development. vol. 15, pp. 807-826 (2001).
Morino et al. “Eukaryotic Translation Initiation Factor 4E (eIF4E) Binding Site and the Middle One-Third of eIF4GI Constitute the Core Domain for Cap-Dependent Translation, and the C-Terminal One-Third Functions as a Modulatory Region.” Molecular and Cellular Biology. vol. 20, pp. 468-477 (2000).
Cromer et al. “Identification of genes associate with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis.” Oncogene. vol. 23, pp. 2484-2498 (2004).
Park et al. “Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.” Nature. vol. 15, No. 423 (6937), pp. 302-305 (2003).
Brass et al. “Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma.” Human Molecular Genetics. vol. 6, pp. 33-39 (1997).
Bauer et al. “Translation Initiation Factor eIF-4G Is Immunogenic, Overexposed, and Amplified in Patients with Squamous Cell Lung Carcinoma.” Cancer. vol. 92, pp. 822-829 (2001).
Bauer, C. et al. “Overexpression of the Eukaryotic Translation Initiation Factor 4G (EIF4G-1) in Squamous Cell Lung Carcinoma.” International Journal of Cancer. vol. 98, pp. 181-185 (2002).
Fukuchi-Shimogori et al. “Malignant Transformation by Overproduction of Translation Initiation Factor eIF4G.” Cancer Research. vol. 57, pp. 5041-5044 (1997).
Mazumder et al. “Regulated Release of L13a from the 60S Ribosomal Subunit as A Mechanism of Transcript-Specific Translational Control.” Cell. vol. 115, pp. 187-198 (2003).
Miura et al. “Laser Capture Microdissection and Microarray Expression Analysis of Lung Adenocarcinoma Reveals Tobacco Smoking- and Prognosis-related Molecular Profiles.” Cancer Research. vol. 62, pp. 3244-3250 (2002).
Racz et al. “Expression Analysis of Genes at 3q26-q27 Involved in Frequent Amplification in Squamous Cell Lung Carcinoma.” European Journal of Cancer. vol. 35, pp. 641-646 (1999).
Molofsky et al. “Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.” Nature. vol. 425, pp. 962-967 (2003).
Singh and Figg. “Upregulation of the Androgen Receptor During Prostate Cancer Progression.” Cancer Biology and Therapy. vol. 3 pp. 284-285 (2004).
Taplin et al. “Androgen Receptor: A Key Molecule in the Progression of Prostate Cancer to Hormone Independence.” Journal of Cellular Biochemistry. vol. 91, pp. 483-490 (2004).
Liao and Witte. “Autoimmune anti-androgen-receptor antibodies in human serum.” Proceedings of the National Academy of Sciences USA. vol. 82, pp. 8345-8348 (1985).
Latulippe et al. “Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated with Metastatic Disease.” Cancer Research. vol. 62, pp. 4499-4506 (2002).
Luo et al. “Gene Expression Analysis of Prostate Cancers.” Molecular Carcinogenesis. vol. 33, pp. 25-35 (2002).
Luo et al. “Human Prostate Cancer and Benign Prostatic Hyperplasia: Molecular Dissection by Gene Expression Profiling.” Cancer Research. vol. 61, pp. 4683-4688 (2001).
Singh et al. “Gene expression correlates of clinical prostate cancer behavior.” Cancer Cell. vol. 1, pp. 203-209 (2002).
Welsh et al. “Analysis of Gene Expression Indentifies Candidate Markers and Pharmacological Targets in Prostate Cancer.” Cancer Research. vol. 61, pp. 5974-5978 (2001).
Bolstad et al. “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.” Bioinformatics. vol. 19, pp. 185-193 (2003).
Bo et al. “New Feature subset selection procedures for classification of expression profiles.” Genome Biology. vol. 3, No. 4, research0017.1-0017.11 (2002).
Rhodes et al. “Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.” Proceedings of the National Academy of Sciences USA. vol. 101, No. 25, pp. 9309-9314 (2004).
Rhodes et al. “Oncomine: A Cancer Microarray Database and Integrated Data-Mining Platform.” Neoplasia. vol. 6, No. 1, pp. 1-6 (2004).
Wang et al. “Autoantibody Signatures in Prostate Cancer.” New England Journal of Medicine. 353, No. 12, pp. 1224-1235 (2005).
Radmacher et al. “A Paradigm for Class Prediction Using Gene Expression Profiles.” Journal of Computational Biology. vol. 9, No. 3, pp. 505-511 (2002).
Tukey et al. “Tightening the Clinical Trial.” Controlled Clinical Trials. vol. 14, No. 4, pp. 266-285
Chinnaiyan Arul
Wang Xiaoju
Casimir Jones S.C.
Gross Christopher M
Low Christopher
The Regents of the University of Michigan
LandOfFree
Phage microarray profiling of the humoral response to disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phage microarray profiling of the humoral response to disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phage microarray profiling of the humoral response to disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217275